DrugDashboards

Market view

apis mellifica, gelsemium sempervirens, gnaphalium

1 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for apis mellifica, gelsemium sempervirens, gnaphalium, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • Mfr exited
    The Magni Company · apis mellifica, gelsemium sempervirens, gnaphalium
  • Mfr entered
    The Magni Company · apis mellifica, gelsemium sempervirens, gnaphalium

Same drug class

Other molecules FDA puts in Standardized Insect Venom Allergenic Extract, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Apis mellifica, gelsemium sempervirens, gnaphalium in shortage right now?
No. FDA does not currently list Apis mellifica, gelsemium sempervirens, gnaphalium in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Apis mellifica, gelsemium sempervirens, gnaphalium?
1 company has marketed Apis mellifica, gelsemium sempervirens, gnaphalium in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.